DNMT3A governs tyrosine kinase inhibitors responses through IAPs and in a cell senescence-dependent manner in non-small cell lung cancer.
Year: 2023
Type: article
Abstract: tumour-bearing mice, which represented a promising strategy for the effective treatment of NSCLC.
Source: PubMed Central
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4386593215
